medigraphic.com
Órgano Científico Oficial de SOCIEM-UCV

2009, Number 3

<< Back Next >>

Acta Cient Estud 2009; 7 (3)

Candida albicans incidence in patients studied in the City of Puebla, Mexico

Sánchez-Hernández JA, Rivera-Tapia JA, Coyotécatl-García LL, Mendoza-López E

Language: Spanish
References: 16
Page: 191-195
PDF size: 61.89 Kb.


ABSTRACT

No abstract


REFERENCES

  1. Berkhout R, Bial A. Candida albicans. Rev Iberoam Micol 2002; 1: 25-26.

  2. Oliveira MM, Carvalho LP, Gomes MS, Bacellar O, Barros TF, Carvalho EM. Microbiological and Immunolgical Features of Oral Candidiasis. Microbiol Immunol 2007; 51(8): 713-719.

  3. Cheng G, Yeater KM, Hoyer LL. Cellular and Molecular Biology of Candida albicans Estrogen Response. Eukaryot Cell 2006; 5: 180–191.

  4. Okawa Y, Miyauchi M, Takahashi S, Kobayashib H. Comparison of Pathogenicity of Various Candida albicans and C. stellatoidea Strains. Biol. Pharm. Bull 2007; 30(10): 1870-1873.

  5. Chad S, Paul LF. Cytokine and Chemokine Production by Human Oral and Vaginal Epithelial Cells in Response to Candida albicans. Infect Immun 2002; 70(2): 577-583

  6. Lopes CM, Thamara AA, Shizue Y, Mazucheli J, Rosane MP, Estivalet ST. Correlation of Candida species and symptoms among patients with vulvovaginal candidiasis in Maringá, Paraná, Brazil. Rev Iberoam Micol 2004; 21: 202-205.

  7. Buscemi L, Arechavala A, Negroni R. Estudio de las vulvovaginitis agudas en pacientes adultas, sexualmente activas, con especial referencia a la candidiasis, en pacientes del hospital de infecciosas Francisco J. Muñiz. Rev Iberoam Micol 2004; 21: 177-181.

  8. Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases. J Clin Microbiol 2005; 43(5): 2155-2162.

  9. Nyirjesy P. Chronic Vulvovaginal Candidiasis. Am Fam Physician 2001; 63(4): 697-702.

  10. Shi WM, Mei XY, Gao F, Huo K, Shen L, Qin H, Wu Z, Zheng J. Analysis of genital Candida albicans infection by rapid microsatellite markers genotyping. Chin Med J 2007; 120 (11): 975-980.

  11. Cheng G, Wozniak K, Wallig MA, Paul LF, Trupin SR, Hoyer LL. Comparison between Candida albicans Agglutinin-Like Sequence Gene Expression Patterns in Human Clinical Specimens and Models of Vaginal Candidiasis. Infect Immun 2005; 73(3): 1656-1663.

  12. Pirotta MV, Garland SM. Genital Candida Species Detected in Samples from Women in Melbourne, Australia, before and after Treatment with Antibiotics. J Clin Microbiol 2006; 44(9): 3213-3217.

  13. Sobel JD, Zervos M, Reed BD, Hooton T, Soper D, Nyirjesy P, Heine MW, Willems J, Panzer H. Fluconazole Susceptibility of Vaginal Isolates Obtained from Women with Complicated Candida Vaginitis: Clinical Implications. Antimicrob Agents Chemother 2003; 47: 34-38.

  14. Yongmoon H. Synergic Anticandidal Effect of Epigallocatechin-O-gallate Combined with Amphotericin B in a Murine Model of Disseminated Candidiasis and Its Anticandidal Mechanism. Biol. Pharm. Bull 2007; 30(9): 1693-1696.

  15. Mahomed-Yunus S M, Jack DS, Hussain E, Wenjin D, Robert A. Fungicidal Activity of Fluconazole against Candida albicans in a Synthetic Vagina-Simulative Medium. Antimicrob Agents Chemother 2004; 48: 161-167.

  16. Rodriguez CM, Cury EA. Amphotericin Bmetronidazole combination against Candida spp. Rev Iberoam Micol 1998; 15: 78-80.




2020     |     www.medigraphic.com